TransGenic Inc (2342):企業の財務・戦略的SWOT分析

◆英語タイトル:TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12805
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

TransGenic Inc (2342) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The company’s product portfolio and services include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support services, contract services for non-clinical study, mouse related products and antibody related products. TransGenic provides Gene analysis and nonclinical study using disease-animal model. The company’s technologies include, exchangeable Gene-trap method to destroy genes of a mouse and GANP Mouse to produce high-affinity antibodies. It has Kobe research centre located in japan. TransGenic is headquartered in Chuo-ku, Fukuoka City, Japan.

TransGenic Inc Key Recent Developments

Feb 06,2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis
Dec 06,2017: TRANS GENIC to Launch Anti-Indoxyl Sulfate Monoclonal Antibody
Nov 15,2017: TRANS GENIC to Launch New Business (New Subsidiary Company)
Aug 01,2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
TransGenic Inc – Key Facts 6
TransGenic Inc – Key Employees 7
TransGenic Inc – Key Employee Biographies 8
TransGenic Inc – Major Products and Services 9
TransGenic Inc – History 10
TransGenic Inc – Company Statement 14
TransGenic Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 17
Company Overview 17
TransGenic Inc – Business Description 18
Business Segment: Advanced medica 18
Overview 18
Performance 18
Business Segment: CRO 18
Overview 18
Performance 18
Business Segment: Genomics 18
Overview 18
Performance 19
Business Segment: Pathological diagnosis 19
Overview 19
Performance 19
Business Segment: TGBS 19
Overview 19
Performance 19
TransGenic Inc – Corporate Strategy 20
TransGenic Inc – SWOT Analysis 21
SWOT Analysis – Overview 21
TransGenic Inc – Strengths 21
TransGenic Inc – Weaknesses 22
TransGenic Inc – Opportunities 23
TransGenic Inc – Threats 24
TransGenic Inc – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Section 4 – Company’s Lifesciences Financial Deals and Alliances 33
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34
TransGenic Inc, Recent Deals Summary 35
Section 5 – Company’s Recent Developments 36
Feb 06, 2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis 36
Dec 06, 2017: TRANS GENIC to Launch Anti-Indoxyl Sulfate Monoclonal Antibody 37
Nov 15, 2017: TRANS GENIC to Launch New Business (New Subsidiary Company) 38
Aug 01, 2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases 40
Section 6 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
TransGenic Inc, Key Facts 6
TransGenic Inc, Key Employees 7
TransGenic Inc, Key Employee Biographies 8
TransGenic Inc, Major Products and Services 9
TransGenic Inc, History 10
TransGenic Inc, Other Locations 15
TransGenic Inc, Subsidiaries 15
TransGenic Inc, Key Competitors 25
TransGenic Inc, Ratios based on current share price 26
TransGenic Inc, Annual Ratios 27
TransGenic Inc, Annual Ratios (Cont...1) 28
TransGenic Inc, Annual Ratios (Cont...2) 29
TransGenic Inc, Interim Ratios 31
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 34
TransGenic Inc, Recent Deals Summary 35
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List of Figures
TransGenic Inc, Performance Chart (2014 - 2018) 30
TransGenic Inc, Ratio Charts 32
TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 33
TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 34

★海外企業調査レポート[TransGenic Inc (2342):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empresas Publicas De Medellin ESP:企業の戦略的SWOT分析
    Empresas Publicas De Medellin ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • ASCO Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ASCO Group Limited Mergers and …
  • PVI Holdings (formerly Petrovietnam Insurance Joint Stock Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PVI Holdings (formerly Petrovie …
  • Medical Facilities Corp (DR):企業のM&A・提携動向(医療分野)
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient procedures. The hospital provides facilities such as infrastructure, surgical equipment, nursing staff, non-surgical professional services, drugs and supplies, and other support services. It …
  • Eaton Vance Corp.:企業の戦略・SWOT・財務分析
    SummaryEaton Vance Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Ferno-Washington, Inc.:企業の戦略的SWOT分析
    Ferno-Washington, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Datawatch Corporation (DWCH):企業の財務及び戦略的SWOT分析
    Summary Datawatch Corporation (Datawatch) is a software company that provides managed analytic solutions. The company offers products such as data access softwares, monarch software and server tools. Its data access softwares provide accessing of structured and unstructured data providing exploratio …
  • Concho Resources Inc.:企業のM&A・提携・投資分析
    Concho Resources Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Concho Resources Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Zeltia S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zeltia S.A. Mergers and Acquisi …
  • ASB Bank Limited:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "ASB Bank Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Bollore SA (BOL):企業概要、財務及び戦略的SWOT分析
    Summary Bollore SA (Bollore) is a diversified company. The company conducts business activities through transportation and logistics, media and communication, and electricity storage solutions. It provides logistic services, digital media, market research and cinema, plastic films for capacitors and …
  • Neuronetics, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Neuronetics, Inc. (Neuronetics) is a medical device company. The company develops therapies for psychiatric and neurological disorders. It offers NeuroStar TMS Therapy System that is used to treat patients with depressive disorder. Neuronetics develops and commercializes non-invasive therapi …
  • Daehan New Pharm Co., Ltd. (054670):企業概要、財務及び戦略的SWOT分析
    Summary Daehan New Pharm Co., Ltd. (Daehan New Pharm) is a pharmaceutical company. The company develops and distributes generic and ethical pharmaceuticals, herbals and health supplements, and veterinary drugs. It offers pharmaceutical, animal health and nutrition, bioprocess, health suppliments and …
  • The British United Provident Association Ltd:企業の戦略的SWOT分析
    The British United Provident Association Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Diazyme Laboratories Inc:企業の製品パイプライン分析2018
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, po …
  • Adaptive Biotechnologies Corporation:企業のM&A・提携動向(医療機器分野)
    Summary Adaptive Biotechnologies Corporation (Adaptive) is a biotechnology company that offers research services. The company develops next generation sequencing assays for the adaptive immune system. It provides immunoSEQ assay. Adaptive’s immunoSEQ assay utilizes a multiplex PCR strategy to amplif …
  • Lowe Enterprises, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lowe Enterprises, Inc. Mergers …
  • Daewoo Shipbuilding and Marine Engineering Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Daewoo Shipbuilding and Marine …
  • Kawasumi Laboratories Inc (7703):企業の財務・戦略的SWOT分析
    Summary Kawasumi Laboratories Inc (Kawasumi) is a medical device company that manufactures and distributes disposable blood collection and transfusion sets. The company’s product portfolio includes hemodialysis, plasmapheresis, blood banking and transfusion, infusion therapy, andendovascular repair …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆